Clinical trial
Efficacy and Safety of ALGRX 4975 in the Treatment of Postoperative Pain After…
NCT00133133 · AlgoRx Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00133133 |
|---|---|
| Title | Efficacy and Safety of ALGRX 4975 in the Treatment of Postoperative Pain After Gall Bladder Removal |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects After Open Cholecystectomy |
| Lead sponsor | AlgoRx Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Postoperative Pain |
| Intervention type | Drug |
| Interventions | ALGRX 4975 |
| Enrollment | 40 |
| Start date | Jul 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Aug 22, 2005 |
| Last update posted | Dec 20, 2006 |
| Countries | Serbia and Montenegro |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: